- Home
- ACON vs CPHI Comparison
ACON vs CPHI Comparison
Compare ACON & CPHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACON
- CPHI
- Stock Information
- Founded
- ACON 2008
- CPHI N/A
- Country
- ACON United States
- CPHI China
- Employees
- ACON N/A
- CPHI N/A
- Industry
- ACON Retail: Computer Software & Peripheral Equipment
- CPHI Biotechnology: Pharmaceutical Preparations
- Sector
- ACON Technology
- CPHI Health Care
- Exchange
- ACON Nasdaq
- CPHI Nasdaq
- Market Cap
- ACON 4.4M
- CPHI 4.7M
- IPO Year
- ACON 2022
- CPHI N/A
- Fundamental
- Price
- ACON $9.10
- CPHI N/A
- Analyst Decision
- ACON Buy
- CPHI
- Analyst Count
- ACON 2
- CPHI 0
- Target Price
- ACON $22.00
- CPHI N/A
- AVG Volume (30 Days)
- ACON 400.2K
- CPHI 16.8K
- Earning Date
- ACON 11-13-2025
- CPHI 11-12-2025
- Dividend Yield
- ACON N/A
- CPHI N/A
- EPS Growth
- ACON N/A
- CPHI N/A
- EPS
- ACON N/A
- CPHI N/A
- Revenue
- ACON $62,948.00
- CPHI $4,396,201.00
- Revenue This Year
- ACON $145.39
- CPHI N/A
- Revenue Next Year
- ACON $145.45
- CPHI N/A
- P/E Ratio
- ACON N/A
- CPHI N/A
- Revenue Growth
- ACON 16.68
- CPHI N/A
- 52 Week Low
- ACON $6.20
- CPHI $1.20
- 52 Week High
- ACON $3,499.51
- CPHI $3.35
- Technical
- Relative Strength Index (RSI)
- ACON 61.89
- CPHI 54.26
- Support Level
- ACON $7.60
- CPHI $1.81
- Resistance Level
- ACON $12.03
- CPHI $1.97
- Average True Range (ATR)
- ACON 0.73
- CPHI 0.10
- MACD
- ACON 0.14
- CPHI -0.02
- Stochastic Oscillator
- ACON 42.24
- CPHI 60.00
About ACON Aclarion Inc.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.
About CPHI China Pharma Holdings Inc.
China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection and others.